BioClinica, Inc. (BIOC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

BioClinica, Inc. (BioClinica), formerly Bio-Imaging Technologies, Inc. is a provider of clinical trial management solutions to pharmaceutical, biotechnology, and medical device companies. The company categorizes its solutions under three groups, namely, imaging, cardiac safety, and eClinical solutions. Imaging core lab (ICL) solutions of the company facilitate the project personnel to receive, process, and review medical images for clinical trials with special expertise in cardiovascular, inflammatory diseases and gastroenterology, metabolic and endocrinology, musculoskeletal, neuroscience, and oncology areas among others. eClinical solutions help in hastening the clinical trial process. The company’s solutions portfolio includes ICL solutions such as WebSend, BioPACS, and BioREAD; eClinical solutions such as OnPoint CTMS, Express electronic data capture (EDC), Trident interactive response technology (IRT), StudyView, Compass, and Optimizer; and cardiac safety solutions that include ECG measurements, QT studies, blood pressure monitoring, and medical imaging. Further, the company also offers a wide range of eClinical services such as full service EDC, clinical data management, CDISC implementation, and medical coding. The company operates in the US, Europe and Asia Pacific along with its subsidiaries and representative offices. BioClinica is headquartered in Newtown, Pennsylvania, the US.



The company focuses on nurturing partnerships as a key element of its strategy, as it recently partnered with Teda International Cardiovascular Hospital (TICH) to offer clinical and centralized cardiac safety services for domestic and foreign sponsors seeking drug approvals in China.

BioClinica, Inc. Key Recent Developments

Jun 11, 2014: BioClinica Introduces Optimizer Enterprise Suite
May 16, 2014: BioClinica Previews eClinical Product Enhancements at Global User Conference
Mar 26, 2014: BioClinica Inks $30 Million in eClinical Contracts with Two Top 10 Pharma Companies
Mar 06, 2014: Worldwide Clinical Trials Selects BioClinica's OnPoint CTMS To Deliver Trial Management Technology For Global Sponsors
Feb 04, 2014: BioClinica Grows eClinical Results In Europe

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents

Section 1 - About the Company 6
BioClinica, Inc. - Key Facts 6
BioClinica, Inc. - Key Employees 7
BioClinica, Inc. - Key Employee Biographies 9
BioClinica, Inc. - Major Products and Services 10
BioClinica, Inc. - History 11
BioClinica, Inc. - Locations And Subsidiaries 16
Head Office 16
Other Locations and Subsidiaries 16
Section 2 - Company Analysis 18
BioClinica, Inc. - Business Description 18
BioClinica, Inc. - Corporate Strategy 19
BioClinica, Inc. - SWOT Analysis 20
SWOT Analysis - Overview 20
BioClinica, Inc. - Strengths 20
Strength - Product and Services Offerings 20
Strength - Operational Network 20
Strength - Synergy with JLL Partners, Inc. 20
BioClinica, Inc. - Weaknesses 21
Weakness - Business Dependence 21
BioClinica, Inc. - Opportunities 21
Opportunity - Market Prospects: Healthcare IT Domain 21
Opportunity - New Business Contracts 21
Opportunity - Acquisition of Blueprint Clinical, Inc. 21
BioClinica, Inc. - Threats 22
Threat - Intense Competitive Pressures 22
Threat - Rapid Technological Change 22
Threat - Stringent Government Regulations 22
BioClinica, Inc. - Key Competitors 23
Section 3 - Company’s Lifesciences Financial Deals and Alliances 24
BioClinica, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 24
BioClinica, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014 25
BioClinica, Inc., Recent Deals Summary 26
Section 4 - Company’s Recent Developments 27
Jun 11, 2014: BioClinica Introduces Optimizer Enterprise Suite 27
May 16, 2014: BioClinica Previews eClinical Product Enhancements at Global User Conference 27
Mar 26, 2014: BioClinica Inks $30 Million in eClinical Contracts with Two Top 10 Pharma Companies 28
Feb 04, 2014: BioClinica Grows eClinical Results In Europe 29
Jan 28, 2014: Mundipharma Research Becomes the Latest Pharmaceutical Company to Choose BioClinica's Industry-Leading Clinical Trial Management System 29
Nov 12, 2013: BioClinica Announces Innovative Big Data Research Project 30
Jul 16, 2013: David S. Herron Joins BioClinica To Lead Imaging Core Lab Division 30
Jun 20, 2013: Grunenthal Expands Use Of BioClinica's Next Generation Trident IWR/IVR For Global Trial 31
Apr 22, 2013: BioClinica Announces Availability Of Express EDCplus 31
Feb 06, 2013: BioClinica Reports Revenue Of $27.6m In Q4 2012 32
Section 5 - Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables

BioClinica, Inc., Key Facts 6
BioClinica, Inc., Key Employees 7
BioClinica, Inc., Key Employee Biographies 9
BioClinica, Inc., Major Products and Services 10
BioClinica, Inc., History 11
BioClinica, Inc., Other Locations 16
BioClinica, Inc., Subsidiaries 17
BioClinica, Inc., Key Competitors 23
BioClinica, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 24
BioClinica, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014 25
BioClinica, Inc., Recent Deals Summary 26

List of Figures

BioClinica, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 24
BioClinica, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 25

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Bone Degeneration - Pipeline Review, H1 2014

Bone Degeneration - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Bone Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Bone Degeneration - Pipeline Review, H1 2014', provides an overview of the Bone Degeneration's therapeutic pipeline. This ...

Vasomotor Symptoms of Menopause - Pipeline Review, H1 2014

Vasomotor Symptoms of Menopause - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Vasomotor Symptoms of Menopause - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Vasomotor Symptoms of Menopause - Pipeline Review, H1 2014', provides an overview of the Vasomotor Symptoms ...

Peripheral Neuropathic Pain - Pipeline Review, H1 2014

Peripheral Neuropathic Pain - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Peripheral Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Peripheral Neuropathic Pain - Pipeline Review, H1 2014', provides an overview of the Peripheral Neuropathic Pain's ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.